Girl with leukemia in remission after gene treatment

12/10/2012 | New York Times (tiered subscription model), The

A girl with acute lymphoblastic leukemia experienced remission after being treated with an experimental therapy that used a disabled form of HIV to genetically reprogram her immune system to fight the cancer. The girl is the first child to undergo the treatment, and some experts said it could someday serve in place of bone marrow transplants. Novartis has expressed interest in the treatment and has pledged $20 million to establish a research center for it at the University of Pennsylvania.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA